The first month results are primarily about establishing tolerance and building toward therapeutic doses rather than maximizing weight loss
Official product information for semaglutide, liraglutide and tirzepatide all describe reduced appetite, greater fullness or satiety, and lower food intake as key effects
Fibrosis stage is the strongest predictor of mortality in patients with NAFLD, and FDA guidance on treatments for NAFLD stresses the importance not only of liver fat reduction, but also of prevention of fibrosis and reduction of inflammation (28)
Individual results may vary, and treatments should be discussed with a licensed clinician to determine appropriateness
Even so, semaglutide isn't a one-size-fits-all medication, meaning results vary
This includes adopting a balanced diet rich in fruits, vegetables, whole grains, and lean proteins